Ultragenyx Pharmaceutical... (RARE)
NASDAQ: RARE
· Real-Time Price · USD
29.68
0.67 (2.31%)
At close: Aug 15, 2025, 3:59 PM
29.87
0.62%
After-hours: Aug 15, 2025, 07:57 PM EDT
Ultragenyx Pharmaceutical Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 185.34M | 127.06M | 173.73M | 150.62M | 486.87M | 118.55M | 213.58M | 72.58M | 102.06M | 85.77M | 132.94M | 391.65M | 159.87M | 153.99M | 307.58M | 197.54M | 290.88M | 383.79M |
Short-Term Investments | 311.28M | 367.38M | 436.3M | 470.99M | 283.13M | 299.83M | 363.63M | 369.52M | 449.92M | 543.59M | 614.82M | 497.02M | 382.93M | 444.33M | 432.61M | 539.58M | 554.88M | 581.61M |
Long-Term Investments | 54.76M | 68.56M | 135M | 203.09M | 114.07M | 160.4M | 199.9M | 4.04M | 71.83M | 90.41M | 154.5M | 121.35M | 178.71M | 241.12M | 293.86M | 290.46M | 231.74M | 216.38M |
Other Long-Term Assets | 56.82M | 62.37M | 62.68M | 53.87M | 50.38M | 56.15M | 51.73M | 109.97M | 26.49M | 22.26M | 10.7M | 18.29M | 21.14M | 21.22M | 11.62M | 16.42M | 12.67M | 8.93M |
Receivables | 125.36M | 98.84M | 121.8M | 93.3M | 105.98M | 100.25M | 73.39M | 79.26M | 70.52M | 42.99M | 40.45M | 31.16M | 37.21M | 28.37M | 28.43M | 25.38M | 24.72M | 25.03M |
Inventory | 46.5M | 46.03M | 45.01M | 43.33M | 40.14M | 35.91M | 33.97M | 31.8M | 28.26M | 26.62M | 26.77M | 21.85M | 21.08M | 17.81M | 16.23M | 15.19M | 15.08M | 12.46M |
Other Current Assets | 51.31M | 59.84M | 40.29M | 41.37M | 54.7M | 47.73M | 47.62M | 46.03M | 51.38M | 14.66M | 68.93M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 719.79M | 699.15M | 817.12M | 799.61M | 964.64M | 595.97M | 732.18M | 524.16M | 702.14M | 766.34M | 883.9M | 1.01B | 678.54M | 707.52M | 856.6M | 846.88M | 949.49M | 1.07B |
Property-Plant & Equipment | 255.76M | 260.91M | 265.93M | 272.45M | 278.71M | 285.11M | 290.57M | 323.24M | 308.21M | 300.82M | 285.69M | 263.37M | 238.63M | 209.77M | 176.18M | 155.76M | 143.19M | 126.08M |
Goodwill & Intangibles | 219.14M | 220.93M | 222.72M | 209.35M | 210.65M | 209.45M | 210.68M | 201.71M | 202.64M | 203.58M | 204.51M | 202.81M | 203.6M | 204.4M | 175.19M | 175.28M | 175.36M | 175.44M |
Total Long-Term Assets | 586.48M | 612.77M | 686.33M | 738.75M | 653.8M | 711.11M | 758.83M | 713.98M | 609.17M | 617.07M | 661.54M | 605.81M | 642.09M | 676.51M | 665.79M | 637.92M | 562.95M | 526.83M |
Total Assets | 1.31B | 1.31B | 1.5B | 1.54B | 1.62B | 1.31B | 1.49B | 1.24B | 1.31B | 1.38B | 1.55B | 1.62B | 1.32B | 1.38B | 1.52B | 1.48B | 1.51B | 1.6B |
Account Payables | 34.24M | 47.45M | 38.76M | 35.99M | 59.81M | 40.97M | 42.11M | 33.36M | 42.12M | 58.98M | 43.27M | 23.53M | 34.21M | 23.68M | 17.14M | 15.57M | 21.79M | 15.74M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 196.49M | n/a | 167.66M | n/a | 1.48M | 2.96M | 4.44M | 5.87M | 7.61M | n/a | 3.91M | 19.22M |
Short-Term Debt | 75.63M | n/a | n/a | 10.42M | 46.92M | 42.69M | n/a | n/a | n/a | n/a | 11.78M | 11.82M | 11.63M | 11.32M | 11.07M | 10.7M | 10.3M | 9.38M |
Other Current Liabilities | 122.31M | 100.44M | 87.47M | 155.67M | n/a | 97.92M | 142.79M | 132.25M | 130.03M | 92.14M | 113.96M | 110.03M | 110.81M | 73.39M | 71.9M | 43.8M | 39.21M | 39.47M |
Total Current Liabilities | 293.24M | 291.67M | 344.15M | 285.01M | 272.87M | 245.57M | 280.44M | 253.98M | 244.38M | 218.18M | 261.21M | 227.36M | 220.64M | 167.23M | 181.37M | 135.93M | 127.07M | 127.04M |
Long-Term Debt | 782.75M | n/a | n/a | n/a | 842.16M | 848.73M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 351.79M | n/a | n/a | n/a |
Other Long-Term Liabilities | 17.4M | 811.17M | 836.91M | 845.81M | 15.2M | 14.48M | 874.53M | 886.23M | 891.39M | 895.74M | 880.26M | 866.11M | 362.71M | 359.02M | 1M | 348.54M | 344.04M | 340.21M |
Total Long-Term Liabilities | 854.74M | 869.01M | 897.01M | 899.53M | 913.15M | 921.24M | 935.16M | 952.45M | 937.9M | 944.74M | 931.74M | 922.28M | 421.92M | 420.37M | 418.47M | 415.19M | 413.21M | 416.14M |
Total Liabilities | 1.15B | 1.16B | 1.24B | 1.18B | 1.19B | 1.17B | 1.22B | 1.21B | 1.18B | 1.16B | 1.19B | 1.15B | 642.55M | 587.61M | 599.84M | 551.13M | 540.27M | 543.18M |
Total Debt | 882.91M | 38.27M | 40.34M | 34.08M | 926.54M | 932.17M | 43.17M | 12.07M | 25.73M | 28.6M | 31.59M | 34.68M | 37.53M | 39.37M | 41.97M | 44.04M | 46.17M | 46.13M |
Common Stock | 96K | 94K | 92K | 92K | 92K | 83K | 82K | 72K | 71K | 71K | 70K | 70K | 70K | 70K | 69K | 68K | 68K | 67K |
Retained Earnings | -4.22B | -4.11B | -3.96B | -3.82B | -3.69B | -3.56B | -3.39B | -3.26B | -3.1B | -2.94B | -2.78B | -2.63B | -2.38B | -2.23B | -2.07B | -1.95B | -1.88B | -1.76B |
Comprehensive Income | 7.72M | -341K | -643K | 896K | 2.3M | 2.9M | 647K | -2.24M | -3.1M | -3.97M | -6.57M | -10.22M | -8.91M | -6.55M | -1.4M | 54K | 232K | 56K |
Shareholders Equity | 151.29M | 144.25M | 255.3M | 346.83M | 432.42M | 140.26M | 275.41M | 31.71M | 129.03M | 220.48M | 352.49M | 468.83M | 678.07M | 796.42M | 922.56M | 933.67M | 972.17M | 1.05B |
Total Investments | 366.04M | 435.95M | 571.3M | 674.08M | 397.19M | 460.23M | 563.53M | 373.56M | 455.38M | 548.78M | 620.35M | 618.37M | 561.64M | 685.46M | 726.47M | 830.04M | 786.62M | 797.99M |